Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose.
Bertrand D, Laurent C, Lemoine M, Lebourg L, Hanoy M, Le Roy F, Nezam D, Pruteanu D, Grange S, De Nattes T, Lemée V, Guerrot D, Candon S. Bertrand D, et al. Among authors: pruteanu d. Microorganisms. 2024 Apr 2;12(4):722. doi: 10.3390/microorganisms12040722. Microorganisms. 2024. PMID: 38674666 Free PMC article.
Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients.
Bertrand D, Laurent C, Lemée V, Lebourg L, Hanoy M, Le Roy F, Nezam D, Pruteanu D, Grange S, de Nattes T, Lemoine M, Candon S, Guerrot D. Bertrand D, et al. Among authors: pruteanu d. Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1343-1345. doi: 10.2215/CJN.0000000000000241. Epub 2023 Jun 29. Clin J Am Soc Nephrol. 2023. PMID: 37382950 No abstract available.
Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.
Bertrand D, Laurent C, Lemée V, Lebourg L, Hanoy M, Le Roy F, Nezam D, Pruteanu D, Grange S, de Nattes T, Lemoine M, Candon S, Guerrot D. Bertrand D, et al. Among authors: pruteanu d. Kidney Int. 2022 Aug;102(2):440-442. doi: 10.1016/j.kint.2022.05.007. Epub 2022 May 23. Kidney Int. 2022. PMID: 35618097 Free PMC article. No abstract available.
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
Bertrand D, Lemée V, Laurent C, Lemoine M, Hanoy M, Le Roy F, Nezam D, Pruteanu D, Lebourg L, Grange S, Plantier JC, Boyer O, Guerrot D, Candon S. Bertrand D, et al. Among authors: pruteanu d. Am J Transplant. 2022 May;22(5):1498-1500. doi: 10.1111/ajt.16954. Epub 2022 Jan 28. Am J Transplant. 2022. PMID: 35007383 Free PMC article. No abstract available.
Genetic predisposition in pediatric oncology.
Pruteanu DP, Olteanu DE, Cosnarovici R, Mihut E, Nagy V. Pruteanu DP, et al. Med Pharm Rep. 2020 Oct;93(4):323-334. doi: 10.15386/mpr-1576. Epub 2020 Oct 25. Med Pharm Rep. 2020. PMID: 33225257 Free PMC article. Review.